ApexBio monthly revenue
ApexBio
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.2B | +19.4% | +20.1% | NT$1B |
| May 2026 | Jun 17, 2026 | NT$0.1B | -3.6% | -18.1% | NT$0.8B |
| Apr 2026 | May 17, 2026 | NT$0.2B | +6.8% | -19.3% | NT$0.7B |
| Mar 2026 | Apr 17, 2026 | NT$0.1B | -20.7% | -24.1% | NT$0.5B |
| Feb 2026 | Mar 17, 2026 | NT$0.2B | -10.9% | -12.0% | NT$0.4B |
| Jan 2026 | — | NT$0.2B | — | +17.9% | NT$0.2B |
| Dec 2025 | — | NT$0.1B | — | -16.1% | NT$1.9B |
| Nov 2025 | — | NT$0.1B | — | +10.9% | NT$1.8B |
| Oct 2025 | — | NT$0.2B | — | -0.8% | NT$1.7B |
| Sep 2025 | — | NT$0.2B | — | -2.9% | NT$1.5B |
| Aug 2025 | — | NT$0.1B | — | -19.9% | NT$1.3B |
| Jul 2025 | — | NT$0.1B | — | -21.9% | NT$1.2B |
| Jun 2025 | — | NT$0.1B | — | -5.2% | NT$1.1B |
| May 2025 | — | NT$0.2B | — | +22.4% | NT$0.9B |
| Apr 2025 | — | NT$0.2B | — | +33.8% | NT$0.7B |
| Mar 2025 | — | NT$0.2B | — | +43.7% | NT$0.6B |
| Feb 2025 | — | NT$0.2B | — | +56.6% | NT$0.4B |
| Jan 2025 | — | NT$0.2B | — | -11.4% | NT$0.2B |
| Dec 2024 | — | NT$0.2B | — | +55.4% | NT$1.9B |
| Nov 2024 | — | NT$0.1B | — | -23.8% | NT$1.7B |
| Oct 2024 | — | NT$0.2B | — | +16.9% | NT$1.6B |
| Sep 2024 | — | NT$0.2B | — | +61.7% | NT$1.4B |
| Aug 2024 | — | NT$0.2B | — | +24.4% | NT$1.2B |
| Jul 2024 | — | NT$0.1B | — | -6.7% | NT$1B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.